Predictive factors of long-term disease remission after rituximab administration in patients with childhood-onset complicated steroid-dependent nephrotic syndrome: a single-center retrospective study.
Rie OhyamaShuichiro FujinagaKoji SakurayaDaishi HiranoShuichi ItoPublished in: Clinical and experimental nephrology (2023)
For older children with complicated SDNS, RTX appeared to be a suitable disease-modifying therapy without persistent adverse events.